The genetic and molecular basis of muscular dystrophy: roles of cell–matrix linkage in the pathogenesis
- 13 September 2006
- journal article
- review article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 51 (11) , 915-926
- https://doi.org/10.1007/s10038-006-0056-7
Abstract
Journal of Human Genetics, official journal of the Japan Society of Human Genetics, publishes original articles and reviews on all aspects of human genetics, including medical genetics and genomicsKeywords
This publication has 104 references indexed in Scilit:
- Disruption of perlecan binding and matrix assembly by post‐translational or genetic disruption of dystroglycan functionFEBS Letters, 2005
- LARGE2 facilitates the maturation of α-dystroglycan more effectively than LARGEBiochemical and Biophysical Research Communications, 2005
- Fukuyama‐type congenital muscular dystrophy (FCMD) and α‐dystroglycanopathyCongenital Anomalies, 2003
- Human Gene Mutation Database (HGMD®): 2003 updateHuman Mutation, 2003
- Defective integrin switch and matrix composition at alpha 7-deficient myotendinous junctions precede the onset of muscular dystrophy in miceHuman Molecular Genetics, 2003
- Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophyNature, 2002
- Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophiesNature, 2002
- Deficiency of α-Dystroglycan in Muscle–Eye–Brain DiseaseBiochemical and Biophysical Research Communications, 2002
- An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophyNature, 2001
- Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrixNature, 1992